Prediction of early neurological deterioration in acute ischemic stroke patients treated with intravenous thrombolysis. 2023

Tian Tian, and Lanjing Wang, and Jiali Xu, and Yujie Jia, and Kun Xue, and Shuangfeng Huang, and Tong Shen, and Yumin Luo, and Sijie Li, and Lianqiu Min
Department of Neurology, the First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.

A proportion of acute ischemic stroke (AIS) patients suffer from early neurological deterioration (END) within 24 hours following intravenous thrombolysis (IVT), which greatly increases the risk of poor prognosis of these patients. Therefore, we aimed to explore the predictors of early neurological deterioration of ischemic origin (ENDi) in AIS patients after IVT and develop a nomogram prediction model. This study collected 244 AIS patients with post-thrombolysis ENDi as the derivation cohort and 155 patients as the validation cohort. To establish a nomogram prediction model, risk factors were identified by multivariate logistic regression analysis. The results showed that neutrophil to lymphocyte ratio (NLR) (OR 2.616, 95% CI 1.640-4.175, P < 0.001), mean platelet volume (MPV) (OR 3.334, 95% CI 1.351-8.299, P = 0.009), body mass index (BMI) (OR 1.979, 95% CI 1.285-3.048, P = 0.002) and atrial fibrillation (AF) (OR 8.012, 95% CI 1.341-47.873, P = 0.023) were significantly associated with ENDi. The area under the curve of the prediction model constructed from the above four factors was 0.981 (95% CI 0.961-1.000) and the calibration curve was close to the ideal diagonal line. Therefore, this nomogram prediction model exhibited good discrimination and calibration power and might be a reliable and easy-to-use tool to predict post-thrombolysis ENDi in AIS patients.

UI MeSH Term Description Entries
D002545 Brain Ischemia Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION. Cerebral Ischemia,Ischemic Encephalopathy,Encephalopathy, Ischemic,Ischemia, Cerebral,Brain Ischemias,Cerebral Ischemias,Ischemia, Brain,Ischemias, Cerebral,Ischemic Encephalopathies
D005343 Fibrinolytic Agents Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. Antithrombic Drug,Antithrombotic Agent,Antithrombotic Agents,Fibrinolytic Agent,Fibrinolytic Drug,Thrombolytic Agent,Thrombolytic Agents,Thrombolytic Drug,Antithrombic Drugs,Fibrinolytic Drugs,Thrombolytic Drugs,Agent, Antithrombotic,Agent, Fibrinolytic,Agent, Thrombolytic,Agents, Antithrombotic,Drug, Antithrombic,Drug, Fibrinolytic,Drug, Thrombolytic,Drugs, Antithrombic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000083242 Ischemic Stroke Stroke due to BRAIN ISCHEMIA resulting in interruption or reduction of blood flow to a part of the brain. When obstruction is due to a BLOOD CLOT formed within in a cerebral blood vessel it is a thrombotic stroke. When obstruction is formed elsewhere and moved to block a cerebral blood vessel (see CEREBRAL EMBOLISM) it is referred to as embolic stroke. Wake-up stroke refers to ischemic stroke occurring during sleep while cryptogenic stroke refers to ischemic stroke of unknown origin. Acute Ischemic Stroke,Cryptogenic Embolism Stroke,Cryptogenic Ischemic Stroke,Cryptogenic Stroke,Ischaemic Stroke,Wake-up Stroke,Acute Ischemic Strokes,Cryptogenic Embolism Strokes,Cryptogenic Ischemic Strokes,Cryptogenic Strokes,Embolism Stroke, Cryptogenic,Ischaemic Strokes,Ischemic Stroke, Acute,Ischemic Stroke, Cryptogenic,Ischemic Strokes,Stroke, Acute Ischemic,Stroke, Cryptogenic,Stroke, Cryptogenic Embolism,Stroke, Cryptogenic Ischemic,Stroke, Ischaemic,Stroke, Ischemic,Stroke, Wake-up,Wake up Stroke,Wake-up Strokes
D015912 Thrombolytic Therapy Use of infusions of FIBRINOLYTIC AGENTS to destroy or dissolve thrombi in blood vessels or bypass grafts. Fibrinolytic Therapy,Thrombolysis, Therapeutic,Therapeutic Thrombolysis,Therapy, Fibrinolytic,Therapy, Thrombolytic,Fibrinolytic Therapies,Therapeutic Thrombolyses,Therapies, Fibrinolytic,Therapies, Thrombolytic,Thrombolyses, Therapeutic,Thrombolytic Therapies
D020521 Stroke A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810) Apoplexy,Cerebral Stroke,Cerebrovascular Accident,Cerebrovascular Apoplexy,Vascular Accident, Brain,CVA (Cerebrovascular Accident),Cerebrovascular Accident, Acute,Cerebrovascular Stroke,Stroke, Acute,Acute Cerebrovascular Accident,Acute Cerebrovascular Accidents,Acute Stroke,Acute Strokes,Apoplexy, Cerebrovascular,Brain Vascular Accident,Brain Vascular Accidents,CVAs (Cerebrovascular Accident),Cerebral Strokes,Cerebrovascular Accidents,Cerebrovascular Accidents, Acute,Cerebrovascular Strokes,Stroke, Cerebral,Stroke, Cerebrovascular,Strokes,Strokes, Acute,Strokes, Cerebral,Strokes, Cerebrovascular,Vascular Accidents, Brain

Related Publications

Tian Tian, and Lanjing Wang, and Jiali Xu, and Yujie Jia, and Kun Xue, and Shuangfeng Huang, and Tong Shen, and Yumin Luo, and Sijie Li, and Lianqiu Min
August 2025, Journal of the Formosan Medical Association = Taiwan yi zhi,
Tian Tian, and Lanjing Wang, and Jiali Xu, and Yujie Jia, and Kun Xue, and Shuangfeng Huang, and Tong Shen, and Yumin Luo, and Sijie Li, and Lianqiu Min
January 2022, Frontiers in neurology,
Tian Tian, and Lanjing Wang, and Jiali Xu, and Yujie Jia, and Kun Xue, and Shuangfeng Huang, and Tong Shen, and Yumin Luo, and Sijie Li, and Lianqiu Min
January 2022, Frontiers in aging neuroscience,
Tian Tian, and Lanjing Wang, and Jiali Xu, and Yujie Jia, and Kun Xue, and Shuangfeng Huang, and Tong Shen, and Yumin Luo, and Sijie Li, and Lianqiu Min
August 2025, Journal of the Formosan Medical Association = Taiwan yi zhi,
Tian Tian, and Lanjing Wang, and Jiali Xu, and Yujie Jia, and Kun Xue, and Shuangfeng Huang, and Tong Shen, and Yumin Luo, and Sijie Li, and Lianqiu Min
January 2024, Frontiers in neuroscience,
Tian Tian, and Lanjing Wang, and Jiali Xu, and Yujie Jia, and Kun Xue, and Shuangfeng Huang, and Tong Shen, and Yumin Luo, and Sijie Li, and Lianqiu Min
January 2023, Technology and health care : official journal of the European Society for Engineering and Medicine,
Tian Tian, and Lanjing Wang, and Jiali Xu, and Yujie Jia, and Kun Xue, and Shuangfeng Huang, and Tong Shen, and Yumin Luo, and Sijie Li, and Lianqiu Min
February 2025, World neurosurgery,
Tian Tian, and Lanjing Wang, and Jiali Xu, and Yujie Jia, and Kun Xue, and Shuangfeng Huang, and Tong Shen, and Yumin Luo, and Sijie Li, and Lianqiu Min
January 2025, Frontiers in neurology,
Tian Tian, and Lanjing Wang, and Jiali Xu, and Yujie Jia, and Kun Xue, and Shuangfeng Huang, and Tong Shen, and Yumin Luo, and Sijie Li, and Lianqiu Min
August 2025, Journal of the Formosan Medical Association = Taiwan yi zhi,
Tian Tian, and Lanjing Wang, and Jiali Xu, and Yujie Jia, and Kun Xue, and Shuangfeng Huang, and Tong Shen, and Yumin Luo, and Sijie Li, and Lianqiu Min
January 2024, Heliyon,
Copied contents to your clipboard!